DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Peiseler M, Liebscher T, Sebode M. et al.
Efficacy and Limitations of Budesonide as a Second-Line Treatment for Patients With Autoimmune Hepatitis.
Clin Gastroenterol Hepatol 2017 pii: S1542-3565(17)30060-5.
DOI: 10.1016/j.cgh.2016.12.040
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.